Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc       US6285301072

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 9 884 M
EBIT 2015 2 681 M
Net income 2015 2 106 M
Debt 2015 7 400 M
Yield 2015 -
Sales 2016 10 448 M
EBIT 2016 3 588 M
Net income 2016 2 453 M
Debt 2016 5 547 M
Yield 2016 -
PER 2015 26,48
PER 2016 18,81
EV / Sales 2015 4,40x
EV / Sales 2016 3,98x
Capitalization 36 064 M
More Financials
Company
Mylan N.V., is a pharmaceutical company which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceutical products.It operates through the following businesses: Generic Products, Rx Products, Active Pharmaceutical Ingredients, and Access... 
Sector
Pharmaceuticals
Calendar
05/28 | 04:00pmPresentation
More about the company
Surperformance© ratings of Mylan Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on MYLAN INC
03:45pDJMylan Raises Bid for Generic Drug Maker Perrigo -- 6th Update
12:49pDJMylan Raises Bid for Generic Drug Maker Perrigo -- 5th Update
12:02pDJMylan Raises Bid for Generic Drug Maker Perrigo -- 4th Update
11:07aDJMylan to Make Formal Bid for Perrigo -- 3rd Update
10:56aDJMylan to Make Formal Bid for Perrigo -- 2nd Update
10:37aDJMylan to Make Formal Bid for Perrigo -- Update
10:36aDJMylan Raises Bid for Generic Drug Maker Perrigo
10:22aDJMylan to Make Formal Bid for Perrigo
More news
Sector news : Pharmaceuticals - NEC
07:20p AKORN : EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities C..
06:13p AKORN : SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses o..
04:48p ELI LILLY : Lilly's CYRAMZA® (ramucirumab) Receives Fourth FDA Approval
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/02 Mylan (MYL) Heather M. Bresch on Q4 2014 Results - Earnings Call Transcript
03/02 Mylan Q4 revenues up 15%, Specialty up 38%
03/02 Mylan (MYL) Q4 2014 Results - Earnings Call Webcast
03/02 Mylan EPS in-line, beats on revenue
03/01 Notable earnings after Monday?s close
Comments 
Advertisement
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | US6285301072 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF